BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7511108)

  • 1. Antagonism of substance P and related peptides by RP 67580 and CP-96,345, at tachykinin NK1 receptor sites, in the rat urinary bladder.
    Montier F; Carruette A; Moussaoui S; Boccio D; Garret C
    Eur J Pharmacol; 1994 Jan; 251(1):9-14. PubMed ID: 7511108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
    Meini S; Patacchini R; Maggi CA
    Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of septide-sensitive tachykinin receptors in inositol phospholipid hydrolysis in the rat urinary bladder.
    Torrens Y; Beaujouan JC; Saffroy M; Glowinski J
    Peptides; 1995; 16(4):587-94. PubMed ID: 7479288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
    Ahluwalia A; Giuliani S; Maggi CA
    Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison in different tissue preparations of the in vitro pharmacological profile of RP 67580, a new non-peptide substance P antagonist.
    Carruette A; Moussaoui SM; Champion A; Cottez D; Goniot P; Garret C
    Neuropeptides; 1992 Dec; 23(4):245-50. PubMed ID: 1282222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
    Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of NK receptors in guinea-pig urinary bladder smooth muscle: use of selective antagonists.
    Longmore J; Hill RG
    Eur J Pharmacol; 1992 Nov; 222(1):167-70. PubMed ID: 1281775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
    Hall JM; Flowers JM; Morton IK
    Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum.
    Petitet F; Saffroy M; Torrens Y; Glowinski J; Beaujouan JC
    Eur J Pharmacol; 1993 Oct; 247(2):185-91. PubMed ID: 7506659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
    Floch A; Fardin V; Cavero I
    Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.
    Hall JM; Mitchell D; Morton IK
    Br J Pharmacol; 1994 Jul; 112(3):985-91. PubMed ID: 7522864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of a potent and selective nonpeptide substance P antagonist.
    Garret C; Carruette A; Fardin V; Moussaoui S; Peyronel JF; Blanchard JC; Laduron PM
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10208-12. PubMed ID: 1719549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
    Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
    Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the effects of NK1-receptor antagonists, (+/-)-CP 96,345 and CP 99,994, on agonist-induced responses in guinea-pig trachea.
    Longmore J; Razzaque Z; Shaw D; Hill RG
    Br J Pharmacol; 1994 May; 112(1):176-8. PubMed ID: 7518303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists.
    Beaujouan JC; Heuillet E; Petitet F; Saffroy M; Torrens Y; Glowinski J
    Br J Pharmacol; 1993 Mar; 108(3):793-800. PubMed ID: 7682138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
    Zeng XP; Burcher E
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1295-300. PubMed ID: 7523658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GR 73,632 and [Glu(OBzl)11]substance P are selective agonists for the septide-sensitive tachykinin NK1 receptor in the rat urinary bladder.
    Meini S; Patacchini R; Lecci A; Poulos C; Rovero P; Maggi CA
    Neuropeptides; 1995 Feb; 28(2):99-106. PubMed ID: 7538205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.